Skip to main content
Equibles

UBS Group AG

Position in VCYT — Veracyte, Inc.

CIK 1610520 ZURICH, V8
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26,429,320
+$20,873,226 QoQ
Shares Held
450,014
+160.9% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 367 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. VCYT ranks #20 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 2,521,208 $1,264,032,836
2 DHR
Danaher Corp /De/
 3,243,524 $617,826,447
3 WAT
Waters Corp /De/
 694,851 $260,596,916
4 A
Agilent Technologies, Inc.
 1,574,629 $209,157,967
5 RVTY
Revvity, Inc.
 1,864,464 $207,440,262
6 IDXX
Idexx Laboratories Inc /De
 364,663 $191,973,186
7 DGX
Quest Diagnostics Inc
 888,906 $188,403,625
8 MTD
Mettler Toledo International Inc/
 128,025 $163,553,216

All Filings in VCYT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,429,320 450,014
2026-03-31 $5,556,094 172,496
2025-12-31 $7,264,186 172,546
2025-09-30 $9,082,171 264,555
2025-06-30 $8,391,895 310,466
2025-03-31 $10,454,260 352,589
2024-12-31 $12,436,259 314,047
2024-09-30 $6,153,477 180,772
2024-06-30 $3,349,206 154,555
2024-03-31 $5,255,199 237,148
2023-12-31 $4,665,942 169,609
2023-09-30 $1,766,882 79,126
2023-06-30 $268,860 10,556
2023-03-31 $2,168,005 97,220
2022-12-31 $4,869,702 205,213
2022-09-30 $906,242 54,593
2022-06-30 $1,570,467 78,918
2022-03-31 $4,976,550 180,506
2021-12-31 $3,724,603 90,403
2021-09-30 $341,499 7,352
2021-06-30 $346,265 8,661
2021-03-31 $241,283 4,489
2020-12-31 $152,839 3,123
2020-09-30 $250,530 7,711
2020-06-30 $178,062 6,875
2020-03-31 $1,461,905 60,136